PLoS paper says Zoloft literature ghostwritten

A paper that ran in PLoS said between 18% and 40% of the medical literature on sertaline (Zoloft) that was published in medical journals between 1998 and 2000 was ghostwritten or managed by a single medical education company acting on behalf of the manufacturer.
close

Next Article in Features


The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.